D. E. Shaw & Co. Inc. Has $28.12 Million Stake in Pediatrix Medical Group, Inc. (NYSE:MD)

D. E. Shaw & Co. Inc. trimmed its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 7.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,143,496 shares of the company's stock after selling 182,007 shares during the period. D. E. Shaw & Co. Inc. owned about 2.50% of Pediatrix Medical Group worth $28,123,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the stock. Barclays PLC raised its position in Pediatrix Medical Group by 302.9% during the third quarter. Barclays PLC now owns 142,087 shares of the company's stock valued at $1,646,000 after buying an additional 106,817 shares during the period. Franklin Resources Inc. acquired a new position in Pediatrix Medical Group during the third quarter valued at $598,000. Harbor Capital Advisors Inc. raised its position in Pediatrix Medical Group by 11.9% during the fourth quarter. Harbor Capital Advisors Inc. now owns 53,717 shares of the company's stock valued at $705,000 after buying an additional 5,712 shares during the period. Ritholtz Wealth Management acquired a new position in Pediatrix Medical Group during the fourth quarter valued at $182,000. Finally, SG Americas Securities LLC acquired a new position in Pediatrix Medical Group during the fourth quarter valued at $171,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Up 0.1%

MD stock traded up $0.01 during mid-day trading on Friday, hitting $14.89. The stock had a trading volume of 785,750 shares, compared to its average volume of 853,113. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67. The company has a fifty day moving average of $13.71 and a 200 day moving average of $14.10. The stock has a market capitalization of $1.28 billion, a price-to-earnings ratio of -12.41, a PEG ratio of 1.74 and a beta of 1.26.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.08. The company had revenue of $458.36 million for the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business's revenue was down 7.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.20 EPS. On average, equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on MD shares. Macquarie upped their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Truist Financial dropped their price target on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a research report on Friday, April 11th. UBS Group dropped their price target on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Finally, StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.